EXEL

ExelixisA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

RSI (14)

81.6

Overbought

MACD Hist

0.46

Bullish

ATR (14)

1.81

Available

Vol Z (20)

3.39

Elevated

RET 20D

+17.9%

Positive

Dist 52W High

0.0%

Near High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-10-30

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Uptrend (SMA20 > SMA50 > SMA200)

Momentum

Positive momentum · 20D +17.9% · 60D +28.3%

RSI / MACD

RSI 81.6 (Overbought) · MACD hist +0.46

Volatility

Volatility elevated (Z 3.39)

SMA20

62.69

SMA50

59.39

SMA200

50.91

EMA12

64.96

EMA26

62.55

BB Upper

68.92

BB Mid

62.69

BB Lower

56.45

RET 5D

+6.6%

RET 20D

+17.9%

RET 60D

+28.3%

RET 120D

+40.3%

As of 2026-10-30 • Updated nightlySource: Internal modelMethods & Data